Paladin Capital Group — 2019 Investments
2 investments dated 2019 · listed companies and verified rows first · show all
10x Genomics offers single cell analysis technology, including its Flex assay and Flex Apex product, which use probe-based chemistry and plate-based multiplexing to profile fresh, frozen, and FFPE samples for researchers.
BiotechDeep TechHardwareHealthtechPleasanton, US
Serge Saxonov(Founder)inBen Hindson(Founder)inBrad Crutchfield(Chief Commercial Officer)inJean Philibert(Chief People Officer)Eric S Whitaker(General Counsel)inJustin McAnear(Chief Financial Officer)in
Co-investorsFoothill VenturesForesite CapitalKhosla VenturesOMX VenturesSoftBank Vision FundVenrock+4 more
RiskLens builds SaaS cyber risk quantification software based on the FAIR standard; acquired by Safe Security in 2023.
Spokane, US
Jack Jones(Executive Officer, Director)inSteven Tabacek(Executive Officer, Director)Nicola (Nick) Sanna(Executive Officer)inChad Weinman(Executive Officer)inLeslie Yates(Executive Officer)in
BoardBryan Smith(Executive Officer)
Board seatMourad Yesayan· per SEC Form D
Co-investorsDell Technologies CapitalF-Prime CapitalMassMutual VenturesOsage Venture Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.


















